Product Overview

Cord blood (commonly abbreviated HUCB) CD34+ cells are known to contain hematopoietic stem and progenitor cells, and are ideal for studies relating to transplantation and stem cells as cord blood derived cells tend to be more naïve than similar cells derived from other tissue sources.

High Purity and Viability

Lonza Cord Blood CD34+ Cells are isolated from cord blood mononuclear cells (MNCs) via positive immunomagnetic separation and are guaranteed to have a purity of ≥90% as indicated by CD34+ expressing cells. They are guaranteed to contain  ≥500,000 viable cells. HIV-1 and hepatitis B are not detected for all donors and/or cell lots. A Certificate of Analysis is provided for each cell lot purchased.

Supported by an Optimized Media System

HPGM^TM Hematopoietic Growth Medium is recommended for optimal performance in serum-free culturing (additional cytokines may be necessary depending on application). Alternative media containing serum may also be acceptable. Please contact Scientific Support for serum containing media recommendations.

Lonza guarantees the performance of Clonetics^TM/Poietics^TM cells only if appropriate Clonetics^TM/Poietics^TM media and reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support.